Stock Events

Quest Pharmatech 

C$0.03
4
-C$0.01-14.29% Today

Statistics

Day High
0.03
Day Low
0.03
52W High
0.07
52W Low
0.02
Volume
5,000
Avg. Volume
49,119
Mkt Cap
5.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jul 5
C$0.06
Apr 5
C$0.06
Jan 5
C$0.06
Oct 4
C$0.06
Jul 4
C$0.06
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

12JulExpected
Q2 2022
Q2 2024
-0
0.33
0.66
1
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QPT.V. It's not an investment recommendation.
Alphabet
77422
GOOGL
Apple
67456
AAPL
Microsoft
62868
MSFT
Amazon
58618
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap300.25B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines, competing directly with Quest Pharmatech in the oncology and immunotherapy sectors.
Pfizer
PFE
Mkt Cap164.39B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including innovative medicines and vaccines, directly competing in the biopharmaceutical field.
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Bristol-Myers Squibb Company is a global biopharmaceutical company with a strong portfolio in cancer treatment, immunology, and cardiovascular diseases, making it a direct competitor.
Novartis
NVS
Mkt Cap244.75B
Novartis AG focuses on patented medicines, generics, and biosimilars, with significant investments in research and development in areas overlapping with Quest Pharmatech's interests.
Gilead Sciences
GILD
Mkt Cap98.35B
Gilead Sciences, Inc. is a biopharmaceutical company that researches, develops, and commercializes drugs in areas such as oncology, competing in similar therapeutic areas as Quest Pharmatech.
AMGEN
AMGN
Mkt Cap179.38B
Amgen Inc. is a biotechnology company focusing on cardiovascular disease, oncology/hematology, and other areas, directly competing with Quest Pharmatech in biopharmaceuticals.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie Inc. is a research-based biopharmaceutical company with a strong emphasis on immunology, oncology, and virology, areas that overlap with Quest Pharmatech's focus.
Roche
RHHBY
Mkt Cap272.83B
Roche Holding AG is a pioneer in healthcare, focusing on pharmaceuticals and diagnostics in oncology, immunology, and infectious diseases, making it a competitor.
Astrazeneca
AZN
Mkt Cap271.67B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including in areas competing with Quest Pharmatech.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson is a diverse healthcare company that develops and sells pharmaceuticals, medical devices, and consumer health products, competing across several of Quest Pharmatech's key areas.

About

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company's lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for the potential cancer targets include pancreatic, colon, leukemia, ovarian, and breast cancer. It is also involved in the development of Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. The company is headquartered in Edmonton, Canada.
Show more...
CEO
Dr. Ragupathy Madiyalakan Ph.D.
Country
CA
ISIN
CA74836M1068

Listings

V
CA
QPT.V
US
QPTFF